The Biotech division is one the most strategic asset of the Italian group, that is massively investing in its facilities to expand the expertise and increase the capacity. Olon said that it is developing strong know-how for the development of rDNA peptides and proteins.

Sartorato holds a degree in Chemistry from the University of Pavia and an Executive Mba from management school SDA Bocconi. He has twenty years of technical and managerial experience in roles of increasing responsibility. He previously was CEO of Bidachem and a member of the Presidential Council of Aschimfarma, the Italian association of manufacturers of active and intermediate ingredients for the pharmaceutical industry, which is part of Federchimica.